Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Peiretti

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Anticancer Research|January 31, 2012
Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative studyMarcello Ceccaroni, Giovanni Roviglione, Emanuela Spagnolo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Diaphragmatic surgery during primary cytoreduction for advanced ovarian cancer: peritoneal stripping versus diaphragmatic resectionIgnacio Zapardiel, Michele Peiretti, Vanna Zanagnolo, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 22, 2021
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the LiteratureDaniela Fanni, Michele Peiretti, Valerio Mais, et al.
Current Oncology (Toronto, Ont.)|November 10, 2022
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A ReviewValerio Mais, Maria Luisa Fais, Michele Peiretti, et al.
Gynecologic Oncology|June 2, 2009
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcomeRobert E Bristow, Michele Peiretti, Melissa Gerardi, et al.
Gynecologic Oncology|August 28, 2010
The role of restaging borderline ovarian tumors: single institution experience and review of the literatureIgnacio Zapardiel, Piergiorgio Rosenberg, Michele Peiretti, et al.
Expert Opinion on Pharmacotherapy|August 28, 2019
Systemic therapy for the treatment of endometrial cancerManuela Neri, Michele Peiretti, Gian Benedetto Melis, et al.
Gynecologic Oncology|July 30, 2009
Robotic approach for cervical cancer: comparison with laparotomy: a case control studyAngelo Maggioni, Lucas Minig, Vanna Zanagnolo, et al.
Gynecologic Oncology|May 5, 2009
Pelvic exenteration: ten-year experience at the European Institute of Oncology in MilanAngelo Maggioni, Giovanni Roviglione, Fabio Landoni, et al.
Gynecologic Oncology|August 31, 2010
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experienceMichele Peiretti, Vanna Zanagnolo, Giovanni D Aletti, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Anticancer Research|January 31, 2012
Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative studyMarcello Ceccaroni, Giovanni Roviglione, Emanuela Spagnolo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Diaphragmatic surgery during primary cytoreduction for advanced ovarian cancer: peritoneal stripping versus diaphragmatic resectionIgnacio Zapardiel, Michele Peiretti, Vanna Zanagnolo, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 22, 2021
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the LiteratureDaniela Fanni, Michele Peiretti, Valerio Mais, et al.
Current Oncology (Toronto, Ont.)|November 10, 2022
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A ReviewValerio Mais, Maria Luisa Fais, Michele Peiretti, et al.
Gynecologic Oncology|June 2, 2009
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcomeRobert E Bristow, Michele Peiretti, Melissa Gerardi, et al.
Gynecologic Oncology|August 28, 2010
The role of restaging borderline ovarian tumors: single institution experience and review of the literatureIgnacio Zapardiel, Piergiorgio Rosenberg, Michele Peiretti, et al.
Expert Opinion on Pharmacotherapy|August 28, 2019
Systemic therapy for the treatment of endometrial cancerManuela Neri, Michele Peiretti, Gian Benedetto Melis, et al.
Gynecologic Oncology|July 30, 2009
Robotic approach for cervical cancer: comparison with laparotomy: a case control studyAngelo Maggioni, Lucas Minig, Vanna Zanagnolo, et al.
Gynecologic Oncology|May 5, 2009
Pelvic exenteration: ten-year experience at the European Institute of Oncology in MilanAngelo Maggioni, Giovanni Roviglione, Fabio Landoni, et al.
Gynecologic Oncology|August 31, 2010
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experienceMichele Peiretti, Vanna Zanagnolo, Giovanni D Aletti, et al.
Pageof 5